全文获取类型
收费全文 | 1332篇 |
免费 | 50篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 68篇 |
妇产科学 | 15篇 |
基础医学 | 161篇 |
口腔科学 | 23篇 |
临床医学 | 229篇 |
内科学 | 325篇 |
皮肤病学 | 35篇 |
神经病学 | 35篇 |
特种医学 | 302篇 |
外科学 | 63篇 |
综合类 | 26篇 |
预防医学 | 28篇 |
眼科学 | 9篇 |
药学 | 82篇 |
肿瘤学 | 61篇 |
出版年
2022年 | 5篇 |
2021年 | 11篇 |
2019年 | 11篇 |
2018年 | 9篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 20篇 |
2014年 | 11篇 |
2013年 | 29篇 |
2012年 | 12篇 |
2011年 | 17篇 |
2010年 | 51篇 |
2009年 | 46篇 |
2008年 | 19篇 |
2007年 | 59篇 |
2006年 | 20篇 |
2005年 | 29篇 |
2004年 | 11篇 |
2003年 | 15篇 |
2002年 | 22篇 |
2001年 | 19篇 |
2000年 | 24篇 |
1999年 | 27篇 |
1998年 | 98篇 |
1997年 | 90篇 |
1996年 | 111篇 |
1995年 | 86篇 |
1994年 | 88篇 |
1993年 | 75篇 |
1992年 | 23篇 |
1991年 | 35篇 |
1990年 | 33篇 |
1989年 | 33篇 |
1988年 | 41篇 |
1987年 | 30篇 |
1986年 | 34篇 |
1985年 | 33篇 |
1984年 | 13篇 |
1983年 | 22篇 |
1982年 | 23篇 |
1981年 | 22篇 |
1980年 | 17篇 |
1979年 | 6篇 |
1978年 | 10篇 |
1977年 | 15篇 |
1976年 | 15篇 |
1975年 | 7篇 |
1974年 | 5篇 |
1971年 | 2篇 |
1966年 | 3篇 |
排序方式: 共有1463条查询结果,搜索用时 46 毫秒
1.
2.
3.
4.
Dr Maria Theresia Kaltwasser 《Am J Cardiovasc Drugs》2005,5(5):319-324
OBJECTIVE: To examine the economic consequences of effective antihypertensive treatment using the novel vasodilating beta1-adrenoceptor antagonist nebivolol (Nebilet) from the perspective of the healthcare provider. METHODS: The evaluation was based on a postmarketing surveillance study in Germany involving 8682 moderately hypertensive patients. Using the Framingham Risk Model, the antihypertensive effectiveness of nebivolol after 6 weeks of treatment was extrapolated to estimate the reductions in 10-year risks of cardiovascular events. Data sources included direct costs for medical and invasive cardiovascular interventions in Germany, costs of therapy in the US and the UK, and estimates on the prevalence of cardiovascular events issued by the American Heart Association. RESULTS: Six-week antihypertensive treatment resulted in a DBP reduction of 13.7 mm Hg. The rate of responders, defined as those patients achieving DBP <90 mm Hg, was 70%. SBP was reduced by 26.1 mm Hg. According to the Framingham Risk Model, 313 deaths would be avoided. Coronary heart disease (CHD) could be reduced by 94 cases (from 1339 to 1245 events) and 150 strokes would be avoided (from 518 to 368 events) in a 10-year period. This reduction of 244 cardiovascular events among the 8682 patients investigated corresponded to cost savings of between Euro 250,000 and Euro 2.5 million, depending on the healthcare environment and the intervention applied. CONCLUSION: Treatment of moderately hypertensive patients with nebivolol can be considered cost effective. Nebivolol has the potential to decrease the overall long-term costs of medical care for patients with hypertension. 相似文献
5.
6.
7.
8.
Y Leskinen JP Salenius T Lehtim?ki H Huhtala H Saha 《American journal of kidney diseases》2002,40(3):472-479
BACKGROUND: Knowledge of the prevalence of peripheral arterial disease (PAD) in patients with chronic renal failure (CRF) is limited because of a lack of uniformity in disease definition and recognition. Furthermore, little is known of the prevalence of medial arterial calcification (MAC) in patients with CRF. Our goal is to study the prevalence of PAD and MAC defined by ankle brachial index (ABI) or toe brachial index (TBI) measurements in a Finnish population of patients with CRF consisting of predialysis and dialysis patients, as well as renal transplant recipients. METHODS: We examined 136 patients with CRF and 59 control subjects. Fifty-nine of the patients with CRF had moderate to severe predialysis CRF, 36 patients were on dialysis treatment, and 41 were renal transplant recipients. Mean age of patients was 51.9 +/- 11.5 years, and 39 patients (29%) had diabetes. ABI and TBI were measured by means of photoplethysmography. The definition of PAD required an ABI value of 0.90 or less, a TBI value of 0.60 or less, or a previous positive lower-extremity angiogram result. ABI values of 1.3 or greater or incompressible arteries at ankle level indicated MAC. The presence of claudication was determined by an interview. RESULTS: Prevalences of PAD on this study were 22.0% in patients with predialysis CRF, 30.6% in patients on dialysis treatment, 14.6% in renal transplant recipients, and 1.7% in the control group (P = 0.001). Prevalences of MAC were 23.7%, 41.7%, 23.1%, and 3.4% (P < 0.001), respectively. Only 9 patients had claudication, and 6 of those patients had PAD. CONCLUSION: Both asymptomatic PAD and MAC are common in patients with CRF. Therefore, we recommend the use of both ABI and TBI measurements in the evaluation of PAD in patients with CRF. 相似文献
9.
We used arthrotomography to study the glenoid labrum in 114 patients. Sixty-nine of the patients had anatomic instability of the shoulder (including recurrent dislocation and subluxation of the shoulder), and 45 patients had functional instability of the shoulder (denoted by chronic pain, clicking of the joint, and the sensation that an unstable condition exists without the objective signs of it). Labral tears were revealed arthrotomographically in 86% of the patients with anatomic instability, while only 40% of the patients with functional instability had labral abnormalities, and these were primarily of minor severity. Fifty-six patients (44 of whom had anatomic instability; 12, functional instability) required surgery. The surgical findings were correlated with the arthrotomographic findings, and no false-positive results were revealed. However, arthrotomography demonstrated only part of the pathologic condition of two patients. These results confirm that there is a strong correlation between labral pathologic conditions and anatomic instability of the shoulder. Arthrotomographic studies have a great impact on the selection of therapy in cases of both anatomic and functional instability of the shoulder. 相似文献
10.